🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06689137
Active, not recruiting Observational

Effects of Dexmedetomidine on Postoperative Neurocognitive Disorder

NCT06689137 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-10-13
Last updated
2024-11-14

Condition(s) studied

Neurocognitive DisorderDexmedetomidine InfusionPostoperative Cognitive DysfunctionPostoperative Cognitive Dysfunction(POCD)Laparoscopic Abdominal Surgery

Investigational drug(s) / intervention(s)

mini mental state assessment testmini-cog test

mini mental state assessment test: Anesthesia management during surgery for this disease in the postoperative period should be carefully planned. It will be important to examine the neurocognitive effects of anesthesia management in the postoperative period in this patient group. In this study, the frequently used Mini mental state assessment test and Mini-cog test will be used. With mini mental state assessment, the patient is asked a number of simple questions to evaluate cognitive functions and each question has certain points. Changes in these score levels preoperatively and postoperatively will be compared within each patient. At the end of the study, preoperative and postoperative changes will be compared statistically between the groups.

mini-cog test: Anesthesia management during surgery for this disease in the postoperative period should be carefully planned. It will be important to examine the neurocognitive effects of anesthesia management in the postoperative period in this patient group. In this study, the frequently used Mini mental state assessment test and Mini-cog test will be used.With Mini-cog test, the patient is asked a number of simple questions to evaluate cognitive functions and each question has certain points. Changes in these score levels preoperatively and postoperatively will be compared within each patient. At the end of the study, preoperative and postoperative changes will be compared statistically between the groups.

Study summary

This prospective study involves assessing neurocognitive function in patients undergoing laparotomic gastrointestinal surgery. Mini Mental state Assessment test and Mini-Cog tests will be conducted at multiple intervals preoperatively and postoperatively. Anesthesia management, vital signs, drug consumption, and blood gas values will be recorded throughout the surgery. After all neurocognitive evaluations of the patients are performed at planned intervals for 1 week, the levels of dexmedetomidine and remifentanyl consumed by the patients in the peroperative period will be determined from the anesthesia follow-up sheet and the total duration and amount used will be recorded. At the end of the study, the relationship between neurocognitive values and dexmedetomidine will be compared.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Patients aged 18-65 who will undergo laparotomic lower and upper gastrointestinal system surgery Exclusion Criteria: * American society of anesthesia of 4-5 patients * Patients without voluntary consent * Patients with previous surgery or vertebrobasilar insufficiency * Patients with Carotis stenosis * Patients with a visual analog scale above 4 in the postoperative recovery unit * Patients whose cerebral oxygenation decreased by 15% from the beginning in cerebral oximetry monitoring during the perioperative period * Patients with bleeding that disrupts hemodynamics during follow-up and bleeding greater than 20% of body volume * Patients with postoperative intensive care unit follow-up * Patients with a decrease of more than 20% from the baseline systolic value (based on ward monitoring) during follow-up * Patients with intraoperative ventilation failure, patients with hypercarbia, hypocarbia * Patients whose Patient State Index value falls below 25, which is sufficient for the depth of anesthesia, during anesthesia induction or maintenance. * Patients with known neurological, psychiatric, unstable cardiovascular, renal or hepatic system disease * Patients with Uncontrolled Hypertension * Patients with greater than 1st degree heart block * Patients allergic to α2 adrenergic receptor agonist * Patients who cannot speak and do not know Turkish * Alcohol and substance addicted patients * Patients who have used opioids in the last 24 hours * Patients who developed sepsis during postoperative follow-up * Patients with a history of recurrent surgery

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Haseki Training and Research Hospital Istanbul Turkey (Türkiye)

More Haseki Training and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06689137 on ClinicalTrials.gov ↗ ← All trials in Turkey